Information about Claeyspharma
My details
*
*
*

Claeyspharma (SRL)

BE 0820.858.045

Bredestraat Kouter 69, 9920 Lievegem

Company information

Status
Active

Enterprise number

BE0820.858.045

VAT liability
Yes
Established
24-11-2009
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Claeyspharma

2024 2023 2022 2021
Profit/Loss € 159,323 -18 % € 193,537 -3 % € 199,085 49 % € 133,825
Equity € 1,658,747 11 % € 1,499,424 15 % € 1,305,887 18 % € 1,106,802
Gross margin € 173,336 39 % € 124,373 -25 % € 165,984 48 % € 112,228

Publications from Claeyspharma

Date Publication
10-01-2024 Modification(s) Articles of Association (NL)
16-01-2019 Registered Office (NL)
26-11-2009 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Claeyspharma?
The VAT number of Claeyspharma is BE 0820.858.045.
Wat is the PEPPOL ID of Claeyspharma?
The PEPPOL ID of Claeyspharma is 0208:0820858045. Log in or start a free trial to see the full overview.
When was Claeyspharma founded?
Claeyspharma was founded on 24-11-2009.
What is the address of Claeyspharma?
The current registered office of Claeyspharma is located at Bredestraat Kouter 69, 9920 Lievegem.
When was the last time Claeyspharma filed their annual financial statements?
The most recent financial statements of Claeyspharma were filed on 29-08-2025.
How many employees does Claeyspharma have?
There are currently no employees working at Claeyspharma or no workforce information is available.
What is the annual turnover of Claeyspharma?
At the time of its most recent financial statements, Claeyspharma did not publish any turnover figures. Claeyspharma reported a gross margin of €173,335.77.

Sources